Latest Capital Structure News

Page 4 of 196
Percheron Therapeutics has lodged a prospectus for up to 280 million options linked to its earlier $2.3 million placement, with the securities carrying a $0.01 exercise price and expiring in April 2028. The filing raises no meaningful cash on issue, but could provide up to $2.8 million if all options are later exercised while adding a potentially dilutive layer to the capital structure.
Victor Sage
Victor Sage
4 Nov 2026
My Food Bag will remain NZX-listed after a strategic and ownership review, with organic growth now taking priority. The board is targeting fully imputed dividends of 70% to 90% of NPAT and is considering an additional return of surplus capital after moving into net cash.
Victor Sage
Victor Sage
4 Nov 2026
Schoolblazer has secured binding commitments for a A$5.325 million placement, with proceeds earmarked partly for repayment of its IFM debt facility. The raise includes A$1.75 million of director participation that still requires shareholder approval.
Victor Sage
Victor Sage
3 Nov 2026
Noxopharm has secured a $1.5 million placement and agreed to convert $3.78 million of shareholder notes as it prepares to test SOF-SKN in cutaneous lupus patients. The funding eases an immediate cash constraint, but the package also brings substantial dilution and remains partly subject to shareholder approval.
Ada Torres
Ada Torres
2 Nov 2026
OpenLearning is seeking up to $2.14 million to fund expansion across Southeast Asia, AI development and working capital, with $700,000 already committed. The raising comes with free options and significant insider participation, but remains dependent on shareholder take-up in an ununderwritten entitlement offer.
Victor Sage
Victor Sage
2 Nov 2026
ADX Energy has launched a discounted 2-for-5 renounceable rights issue targeting up to A$5.2 million, with proceeds aimed at Vienna Basin production work and new Austrian gas activity. The raise is only partially underwritten, while the prospectus warns that failure to complete it would create significant going-concern uncertainty.
Victor Sage
Victor Sage
2 Nov 2026
Maverick Minerals has turned its expanded West Arunta portfolio into an active drilling campaign, but the September quarter left the explorer with A$1.503 million in cash and estimated funding for about two quarters. Pokali East assays expected in early 2027 could become the next major test of the strategy.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Osteopore reported record quarterly revenue of A$859,000 in Q3 CY26 as it added market access in Thailand and Saudi Arabia and completed its first customised Hainan implant. The regenerative implant maker remains cash-flow negative, with A$712,000 in cash and A$14 million still available under its convertible note facility.
Victor Sage
Victor Sage
30 Oct 2026
LGP Cannatrek generated A$4.4 million in net operating cash flow on unaudited quarterly revenue of A$26.0 million, providing the first clean look at the merged group’s operations. Cost synergies, Danish production upgrades and UK expansion are advancing, while a pending TGA penalty remains an unresolved risk.
Ada Torres
Ada Torres
30 Oct 2026
Enova Mining has reported encouraging rare earth exploration and metallurgical results across Brazil and Australia, but ended September with just A$333,000 in cash. A proposed A$2 million placement, A$495,200 rights issue and revised 25-for-1 consolidation now sit at the centre of its next phase.
Maxwell Dee
Maxwell Dee
30 Oct 2026
GenusPlus has completed its acquisition of New Zealand telecommunications contractor UCG, extending the group’s communications infrastructure footprint into New Zealand and the Pacific Islands. The upfront consideration was funded from existing cash reserves and a debt facility, but the company has not disclosed the purchase price or expected earnings contribution.
Victor Sage
Victor Sage
30 Oct 2026
ABx Group has completed its $2 million underwritten share purchase plan, with shareholders subscribing for $1.1 million and the remaining shortfall placed through the underwriter. The raising delivers fresh capital but also adds 95.2 million shares and 238.1 million options across the transaction.
Maxwell Dee
Maxwell Dee
30 Oct 2026

Browse the archive

Full archive